US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ブラジル
BOV
NovoCure Ltd (N2VC34) 銘柄情報

NovoCure Ltd (N2VC34)

7.08

0.00

( 0.00% )

更新日時： 00:47:12

NovoCure Ltd (N2VC34) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

7.08

( - )

買値

9.03

売値

9.08

出来高

-

0.00 日の範囲 0.00

5.18 52 週間の範囲 9.29

時価総額

前日終値

7.08

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

R$ 1,656,686

発行済株式数

115,820,940

配当利回り

PER

-11.18

1 株当たり利益 (EPS)

-1.54

歳入

674.41M

純利益

-173.05M

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Op... NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.novocure.com

本社

Baar, Switzerland

設立

2026

NovoCure Ltd is listed in the sector of the ボベスパ (ブラジル) with ticker N2VC34. The last closing price for NovoCure was R$7.08. Over the last year, NovoCure shares have traded in a share price range of R$ 5.18 to R$ 9.29.

NovoCure currently has 115,820,940 shares in issue. The market capitalisation of NovoCure is R$820.01 million. NovoCure has a price to earnings ratio (PE ratio) of -11.18.

As ações da Novocure sobem após resultados promissores de um estudo clínico sobre câncer de pâncreas

/jornal/2026/03/as-acoes-da-novocure-sobem-apos-resultados-promissores-de-um-estudo-clinico-sobre-cancer-de-pancreas/

As ações da Novocure sobem após o restabelecimento dos privilégios de faturamento do Medicare

/jornal/2026/02/as-acoes-da-novocure-sobem-apos-o-restabelecimento-dos-privilegios-de-faturamento-do-medicare/

As ações da Novocure disparam após a aprovação de dispositivo para câncer de pâncreas pela FDA

/jornal/2026/02/as-acoes-da-novocure-disparam-apos-a-aprovacao-de-dispositivo-para-cancer-de-pancreas-pela-fda/

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	-1.66	-18.9931350114	8.74	8.74	7.02	7285	7.47865425	DR
12	1.77	33.3333333333	5.31	9.29	5.29	1351	7.45075281	DR
26	-0.53	-6.96452036794	7.61	9.29	5.18	982	7.03809782	DR
52	-2.06	-22.5382932166	9.14	9.29	5.18	758	6.99885625	DR
156	-12.82	-64.4221105528	19.9	22.3	5	439	8.57203375	DR
260	-31.56	-81.6770186335	38.64	45.39	5	346	11.00425077	DR

N2VC34 - Frequently Asked Questions (FAQ)

What is the current NovoCure Ltd share price?

The current share price of NovoCure Ltd is R$ 7.08

How many NovoCure Ltd shares are in issue?

NovoCure Ltd has 115,820,940 shares in issue

What is the market cap of NovoCure Ltd?

The market capitalisation of NovoCure Ltd is BRL 820.01M

What is the 1 year trading range for NovoCure Ltd share price?

NovoCure Ltd has traded in the range of R$ 5.18 to R$ 9.29 during the past year

What is the PE ratio of NovoCure Ltd?

The price to earnings ratio of NovoCure Ltd is -11.18

What is the cash to sales ratio of NovoCure Ltd?

The cash to sales ratio of NovoCure Ltd is 2.95

What is the registered address of NovoCure Ltd?

The registered address for NovoCure Ltd is Neuhofstrasse 21, Baar, Zug, 6340

What is the NovoCure Ltd website address?

The website address for NovoCure Ltd is www.novocure.com

FormalMHRAconsultant

FormalMHRAconsultant 2分前

Because the deck contains 2026 elements and refinements, my assumption is that NWBO submitted this to the MHRA this year rather than in some earlier form in 2025. But that's ultimately beside the point for what I said earlier my core argument doesn't depend on it: if the November CHM had been the fi

dexprs

Many prefers not to own on a near future flood zone.

US Market News

US Market News 2分前

Allstate to hold Q2 2026 earnings call Aug. 6, 2026July 6, 2026 11:50 AM
PR Newswire (US) class="legendSpanClass"NORTHBROOK, Ill., class="legendSpanClass"July 6, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) announced the sch

DigiTech

DigiTech 3分前

NGEN top pick
AYA
GE
LFMD
INTC
ORCL
MAMA
VLE.TO
ALDX
UUUU

Thanks
Bernard

learningcurve2020

learningcurve2020 3分前

Aka the MAA is in limbo. 🤷‍♀️

train21

train21 3分前

AN R/S is never a good thing for share holders
it seems to me.... FINRA is in the business of aiding these share selling ceos
look at all the r/s in the last 14 months in the $OTC ..........mostly all share selling CEOs who go right back to dumping shares right after the r/

dexprs

It does not look well for the average Joe.

Goats'nCrows

Goats'nCrows 4分前

This strategy is without doubt the most "law review kid" move I have ever seen.

Every _______ time. They are perpetually worthless in a crunch in a court room, but always ready to tell you when the comma is out of place.

Un________ believable.

fredscott36

fredscott36 4分前

.....WHAT DOES ARTIFICAL INTELLIGENCE SAY ABOUT UWBI and UWB-R and FCNCA and LIBOR............????........

......gobbledygook nonsense..........HORRIFICALLY WRONG WRONG WRONG.......pathetic......

....A-I has the uwbi cusips WIPED OUT, worthless and cancelled.........A-I

IstvantheHun

IstvantheHun 4分前

That would be sweet, serious big money, even if short lived. I believe Wendy's (WEN) realized gains in the past due to the same effect.

imanjen13

imanjen13 6分前

I'm curious as to where you got this information.
I did see a bid by CDEL for 200k shares at .37 that seems to have filled. Double counted it accounts for most of todays volume. Let's hope this is a Game Changer instead of a GameStopper.
I hear things get better with Coca Cola.

GTF

OK. You don't own shares of either company and won't take a minute to research it...and you tell me I'm wrong. LOL. Get yourself a better life than trolling. I do have shares in both and very much know what the reality is.

JRoon71

JRoon71 7分前

RMB, I agree. However, I wonder if we place too much emphasis on the amount of "pull" a big pharma company has with regulators and health commissions in Europe. Vascepa has always been a bit of an "enigma" in the drug industry. Very often being perceived as "just fish oil", and constantly having to

The Truth Hurts

The Truth Hurts 7分前

Bringing this back up. PCGC market cap now up to today $200k PPS $.60

For the three months ended March 31, 2026, the Company generated revenue of $4,408,532
-gross profit of $1,836,015,
-income from operations of $1,325,329
-net income of $1,378,294.
-Net i

learningcurve2020

learningcurve2020 7分前

Suggest you study the PPHM takeover if you ever really want to get anywhere. They jettisoned the go-nowhere biologic that held retail hostage for two decades then built the CDMO.

makinezmoney

makinezmoney 7分前

$INNI: There should be an announcement in July............

I read that on the Twitter verse last month.

All I know is I'm quietly accumulating.......... don't announce it much here more unless its a large swallow.

GO $INNI

Aquahoya

Aquahoya 7分前

BigBadWolf

BigBadWolf 7分前

The Texas Stock Exchange officially began its phased rollout in Dallas, initially opening for member firms to trade designated test stocks. A wider rollout of thousands of publicly traded equities will occur in phases over the course of the month, eventually leading to full market availability.

Bngo

Glad that you are back on the long and strong side of Elite team and have decided to stop playing games with your investments.
New cash flow value has moved from $2.57 to $3.28.
https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-eltp/elite-pharmaceuticals/valuation

Docmercedes

Docmercedes 8分前

I know that you are well versed in engineering. So , this wouldn’t be connected to the coating business that slipped up from us years ago ? Ty

Docmercedes

Docmercedes 8分前

I know that you are well versed in engineering. So , this wouldn’t be connected to the coating business that slipped up from us years ago ? Ty

The Truth Hurts

The Truth Hurts 8分前

Bringing this back up. PCGC market cap now up to today $200k PPS $.60

For the three months ended March 31, 2026, the Company generated revenue of $4,408,532
-gross profit of $1,836,015,
-income from operations of $1,325,329
-net income of $1,378,294.
-Net i

mrwrn2010

mrwrn2010 8分前

Where do they find these guys? Account created over 10 years ago, 0 posts… until the 2 today so far trying for a fake pump.

Feels like half the people posting here are engaged in psy ops against Elite.

manibiotech

manibiotech 8分前

This will be submitted as supplemental or supporting data , not a replacement for already submitted peer reviewed data with publication . And MHRA will review it through their own fine comb . So your assertion that journal publication is required is inaccurate .

Eli's Gone

Eli's Gone 8分前

Driver Top 10 Sun Jul 12 Quaker State 400 EchoPark Speedway 60/160/260 7:00pm/et TNT Race 20 of 36

https://investorshub.advfn.com/uimage/uploads/2026/7/6/dezmhTop_10_for_Race_20_EchoPark.jpg

Pt Astra International TBK (PK)

Banque Cantonale Vaudoise

Hutchison Port (PK)

Verisante Technology

Goshawk Global Balanced ...

CAC Consumer Staples

Bluejay Diagnostics

Fctbpce2.2%31jul26 Fctbp...

Direxion Daily Adbe Bull...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。